Whether we’re bridging gaps or breaking down barriers, our goal is to serve patients.
Everyone has their own story. We reduce harm, celebrate success, and offer unconditional support.
We designed the company to align its success with patients, providers and partners. If ever there’s doubt, patients come first.
The more we grow, the more people are counting on us.
Most patients and caregivers have been let down before – and deserve better. We take this seriously.
We’re grateful to our customers and investors for recognizing that when we do the right thing - expand access to affordable, effective treatment – everyone wins.
Our program is built on science, guided by medical leaders with decades of experience treating over 50,000 patients.
The addiction treatment industry has been plagued by harmful misinformation for too long.
Our team wrote the book on best practices. Technology helps us learn and improve.
Statistics can reverse stigma – but to drive true change, we must foster human connection.
Boulder empowers compassionate thought leaders, arming our team with tools to educate and advocate. We meet skepticism with patience; hostility with kindness.
We’re thoughtful about the language we use, and always glad to share patient stories that show why this work matters.
Despite national attention, the opioid crisis is expected to worsen over the next 5 years. We intend to change that.
Boulder’s mission is to transform how addiction is perceived, medicine is practiced, and care is delivered.
Innovation must be broad, dramatic, and fast. We’re charging forward defiantly – we can’t afford not to.
It’s rare to find a truly diverse team. We’re so proud to be building one.
The Boulder Family is comprised of world-class clinicians, researchers, business strategists, technologists – each with very unique life stories and perspectives.
We’re committed to bringing the best version of ourselves to others. Together, we’ll work tirelessly to achieve our mission.
Founder & Chief Executive Officer
Dr. Amanda Wilson, MD, MA, FASAM
Founder & Chief Medical Officer
Mary Jean “MJ” Darby, RN
Founder & Chief Development Officer
Chief Technology Officer
Nameeta Dookeran, MD, MS, FASAM, FACP
Medical Director, Quality & Compliance
Dr. Stephen Martin, MD, EdM
Medical Director, Head of Ethics
Andy Mendenhall, MD
Advising Medical Director
Cara Chandler, PhD, RN, CNL
Clinical Program Director
Raeann LeBlanc, PhD, DNP
Clinical Research & Education
Ginger Ross, CRSW, Psychology, US Army Veteran
Program Manager, Certified Peer Coaching
Jordon Bosse, PhD, RN
Project Manager: Research and Education
Dr. Lisa Chiodo, PhD
Mark Shatsky, DO
Advising Chief Medical Informatics Officer
Cheryl Cohen, LPC, CADC
Executive Assistant & Project Manager
Director of Engineering
April Fitzsimmons, RN
Co-Founder and Partner First Round Capital
Veteran healthcare and technology executive
Investor, Board Observer - Acumen America, Director
Andrey Ostrovsky, MD
Former Chief Medical Officer, US Medicaid
John D. Musil, Pharm.D., FACA
Founder, Chairman, Avella Specialty Pharmacy (Previously the nation's largest independent specialty pharmacy. Recently acquired by Optum)
Investor - BoxGroup, Partner
Healthcare Investor and Advisor